miRNA-1236 inhibits HIV-1 infection of monocytes by repressing translation of cellular factor VprBP

PLoS One. 2014 Jun 16;9(6):e99535. doi: 10.1371/journal.pone.0099535. eCollection 2014.

Abstract

Primary monocytes are refractory to HIV-1 infection and become permissive upon differentiation into monocyte-derived dendritic cells (MDDCs) or macrophages. Multiple mechanisms have been proposed to interpret HIV-1 restriction in monocytes. Human cellular miRNAs can modulate HIV-1 infection by targeting either conserved regions of the HIV-1 genome or host gene transcripts. We have recently reported that the translation of host protein pur-alpha is repressed by abundant cellular miRNAs to inhibit HIV-1 infection in monocytes. Here, we report that the transcript of another cellular factor, VprBP [Vpr (HIV-1)-binding protein], was repressed by cellular miRNA-1236, which contributes to HIV-1 restriction in monocytes. Transfection of miR-1236 inhibitors enhanced translation of VprBP in monocytes and significantly promoted viral infection; exogenous input of synthesized miR-1236 mimics into MDDCs suppressed translation of VprBP, and, accordingly, significantly impaired viral infection. Our data emphasize the role of miRNA in modulating differentiation-dependent susceptibility of the host cell to HIV-1 infection. Understanding the modulation of HIV-1 infection by cellular miRNAs may provide key small RNAs or the identification of new important protein targets regulated by miRNAs for the development of antiviral strategies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3' Untranslated Regions / genetics
  • Carrier Proteins / biosynthesis
  • Carrier Proteins / genetics
  • Carrier Proteins / physiology*
  • Cell Differentiation
  • Cells, Cultured
  • Dendritic Cells / cytology
  • Dendritic Cells / virology
  • Gene Expression Regulation / genetics*
  • Gene Knockdown Techniques
  • Genes, Reporter
  • Genetic Vectors
  • HEK293 Cells
  • HIV-1 / physiology*
  • Host Specificity
  • Host-Pathogen Interactions
  • Humans
  • MicroRNAs / agonists
  • MicroRNAs / antagonists & inhibitors
  • MicroRNAs / physiology*
  • Monocytes / metabolism
  • Monocytes / virology*
  • Protein Biosynthesis / genetics*
  • Protein Serine-Threonine Kinases
  • RNA, Small Interfering / pharmacology
  • Transfection
  • Ubiquitin-Protein Ligases

Substances

  • 3' Untranslated Regions
  • Carrier Proteins
  • MIRN1236 microRNA, human
  • MicroRNAs
  • RNA, Small Interfering
  • Ubiquitin-Protein Ligases
  • DCAF1 protein, human
  • Protein Serine-Threonine Kinases

Grants and funding

This work was supported by grants to J.H.W. from the Interdisciplinary and Collaboration team of Chinese Academy of Sciences; the Natural Science Foundation of China (No. 81171567), and the National Basic Research Program of China (973 Program) (2012CB519004). J.H.W. gratefully acknowledges the support of the Sanofi-Aventis-SIBS Scholarship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.